Dissecting the dynamic transcriptional landscape of early T helper cell differentiation into Th1, Th2, and Th1/2 hybrid cells. 2022

Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
Systems Biology of Inflammation, German Rheumatism Research Center (DRFZ), a Leibniz Institute, Berlin, Germany.

Selective differentiation of CD4+ T helper (Th) cells into specialized subsets such as Th1 and Th2 cells is a key element of the adaptive immune system driving appropriate immune responses. Besides those canonical Th-cell lineages, hybrid phenotypes such as Th1/2 cells arise in vivo, and their generation could be reproduced in vitro. While master-regulator transcription factors like T-bet for Th1 and GATA-3 for Th2 cells drive and maintain differentiation into the canonical lineages, the transcriptional architecture of hybrid phenotypes is less well understood. In particular, it has remained unclear whether a hybrid phenotype implies a mixture of the effects of several canonical lineages for each gene, or rather a bimodal behavior across genes. Th-cell differentiation is a dynamic process in which the regulatory factors are modulated over time, but longitudinal studies of Th-cell differentiation are sparse. Here, we present a dynamic transcriptome analysis following Th-cell differentiation into Th1, Th2, and Th1/2 hybrid cells at 3-h time intervals in the first hours after stimulation. We identified an early bifurcation point in gene expression programs, and we found that only a minority of ~20% of Th cell-specific genes showed mixed effects from both Th1 and Th2 cells on Th1/2 hybrid cells. While most genes followed either Th1- or Th2-cell gene expression, another fraction of ~20% of genes followed a Th1 and Th2 cell-independent transcriptional program associated with the transcription factors STAT1 and STAT4. Overall, our results emphasize the key role of high-resolution longitudinal data for the characterization of cellular phenotypes.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006822 Hybrid Cells Any cell, other than a ZYGOTE, that contains elements (such as NUCLEI and CYTOPLASM) from two or more different cells, usually produced by artificial CELL FUSION. Somatic Cell Hybrids,Cell Hybrid, Somatic,Cell Hybrids, Somatic,Cell, Hybrid,Cells, Hybrid,Hybrid Cell,Hybrid, Somatic Cell,Hybrids, Somatic Cell,Somatic Cell Hybrid
D018417 Th1 Cells A subset of helper-inducer T-lymphocytes which synthesize and secrete INTERLEUKIN-2; INTERFERON-GAMMA; and INTERLEUKIN-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions. T Helper 1 Cells,TH-1 Cells,Type 1 Helper T Cells,Cell, TH-1,Cell, Th1,Cells, TH-1,Cells, Th1,TH 1 Cells,TH-1 Cell,Th1 Cell
D018418 Th2 Cells A subset of helper-inducer T-lymphocytes which synthesize and secrete the INTERLEUKINS IL-4; IL-5; IL-6; and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses. T Helper 2 Cell,T Helper2 Cell,TH-2 Cell,Th2 Cell,Type-2 Helper T Cell,T Helper 2 Cells,T Helper2 Cells,TH-2 Cells,Type-2 Helper T Cells,Cell, T Helper2,Cell, TH-2,Cell, Th2,Cells, T Helper2,Cells, TH-2,Cells, Th2,TH 2 Cell,TH 2 Cells,Type 2 Helper T Cell,Type 2 Helper T Cells

Related Publications

Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
August 2000, The Journal of experimental medicine,
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
March 2019, Immunology letters,
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
December 2000, The Journal of experimental medicine,
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
December 1992, Biochemistry,
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
May 2024, Immunology letters,
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
January 2003, Methods in molecular biology (Clifton, N.J.),
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
December 2023, International immunopharmacology,
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
January 1999, Microbes and infection,
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
November 1997, Current biology : CB,
Philipp Burt, and Michael Peine, and Caroline Peine, and Zuzanna Borek, and Sebastian Serve, and Michael Floßdorf, and Ahmed N Hegazy, and Thomas Höfer, and Max Löhning, and Kevin Thurley
July 2000, The Journal of experimental medicine,
Copied contents to your clipboard!